SLC2A3 and Hypoglycemia: Recently, Lynch et al. [40] reported that the fetal hypoglycemia observed at mid-gestation as a result of fetal placental SLC2A3 RNAi was associated with a 70% increase in umbilical CSH concentrations, with no impact on uterine vein concentrations.